Dr M Babaiah

Dr M Babaiah

Dr M Babaiah

Qualification: MBBS, MD (AIIMS)
Specialty:  Radiation Oncology
Designation: : Medical Director and Chief Radiation Oncologist
Experience: 40 Years
Hitec City


About Dr M Babaiah

Dr. M Babaiah is the Medical Director and Chief Radiation Oncologist at Medicover Cancer Institute, Hyderabad. He has made immense contribution towards cancer care in the twin states of Telangana and Andhra Pradesh during his clinical practice covering more than three decades. His vision and pursuance of excellence has changed the face of practice of Radiation Oncology in twin states. He was the first Radiation Oncologist in twin states to bring computerized treatment planning system in mid 80s for accurate delivery of radiation to the tumors. Dr. Babaiah was the first Radiation Oncologist in South India, who started innovative and revolutionary cancer treatment technologies like IMRT, IGRT, SRT and SRS and made them available for the cancer patients in twin states. His never ending desire for superior technology made it possible to procure first RAPID ARC treatment technology at Hyderabad in a corporate setup for the first time in India.

Area Of Expertise:

  • Intensity Modulated Radiotherapy (IMRT)
  • Image Guided Radiotherapy (IGRT)
  • Rapid Arc
  • Stereo-tactic Radiotherapy (SRT) and Stereo-tactic Radiosurgery (SRS)
  • Stereo-tactic Body Radiotherapy (SBRT)
  • Brachytherapy

Past Experience:

  • 1988 – 2004: Head of the Department of Oncology, Medwin Cancer Centre, Hyderabad.
  • 2004 – 2012:  Director, Yashoda Cancer Institute, Hyderabad.
  • 2012 – 2021: Medical Director, American Oncology Institute (AOI), Hyderabad.

Awards & Recognisition:

  • Nargis Dutt Foundation Award in 1992
  • Pioneer in Oncology award in 2009
  • Rayalaseema Ratna Award in 2011
  • Ugadi Puraskaram Award from A.P. Govt. in 2012

Professional Training and Experience:

  • Training of MD Radiation Oncology students from 1981 – 1983 at AIIMS as Registrar.
  • Started first DNB course in Radiation Oncology in twin states in 1999.
  • Professor of Oncology, Deccan Medical College from 1995 – 2012.


  • Tumors of PINEAL region J. Clinical Radiotherapy Oncology. 6(2) : 20-23, 1991
  • Cutaneous Metastasis of occult primary carcinoma of Thyroid detected by FNAC – a case report. J. Clinical Radiotherapy Oncology. Vol.4, No.2: 43-45, June – 2004.
  • Experience with Alpha-2 interferon at Medwin cancer Centre, Hyderabad, India – A preliminary report.Ind.J. Med & Ped Oncology. Vol.16 : 25-31, 1995.
  • Metastasis skull secondaries from Adenocarcinoma of the Oesophagus. J. Clinical Radiotherapy Oncology. 8(1) : 46 – 48, 1993.
  • Volumetric modulated ARC-Based hypo fractionated stereotactic radiotherapy for the treatment of selected intracranial arteriovenous malformations: Dosimetric report and early clinical experience.Int.J. Radiation Oncology Biol. Phys., pp. 1-7, 2011
  • Radiotherapy for large cutaneous angiosarcoma of face with Rapid Arc (VMAT). Int.J.Cancer Ther Oncol 2015; 3(2):03023.
  • Comparative dosimetric analysis of IMRT and VMAT (Rapid Arc) in brain, head and neck, breast and prostate malignancies. Int.J.Cancer Ther Oncol 2015; 3(1):03019.
  • Estimation of linear quadratic (LQ) model parameter alpha/beta (α/β) and biologically effective dose (BED) for acute normal tissue reactions in head and neck malignancies. Int.J.Cancer Ther Oncol 2016; 4(4):449.

Covid-19: All you need to know.